Characterization of μ Opioid Receptor Binding and G Protein Coupling in Rat Hypothalamus, Spinal Cord, and Primary Afferent Neurons during Inflammatory Pain

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 2, 2004, Pages 712-718

  Shaqura, Mohammed A ^a   Zöllner, Christian ^a   Mousa, Shaaban A ^a   Stein, Christoph ^a   Schäfer, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FREUND ADJUVANT; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; OPIATE; SULFUR;

ADAPTATION; ANALGESIA; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BINDING COMPETITION; BINDING SITE; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; METABOLISM; MUSCLE SPINDLE AFFERENT NERVE; NONHUMAN; PAIN; PATHOLOGY; PAW EDEMA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RAT STRAIN; RECEPTOR UPREGULATION; SENSORY NERVE CELL; SPINAL CORD; SPINAL GANGLION;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NEURONS, AFFERENT; PAIN; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; SPINAL CORD; SULFUR RADIOISOTOPES;

EID: 1642457220     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.057257     Document Type: Article

References (36)

1. Alvares D and Fitzgerald M (1999) Building blocks of pain: the regulation of key molecules in spinal sensory neurones during development and following peripheral axotomy. Pain Suppl 6:7-85.
2. Antonijevic I, Mousa SA, Schäfer M, and Stein (1995) Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 15:165-172.
3. 35S]GTPγS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors. Cell Signal 14:829-837.
4. Basbaum AI and Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309-338.
5. Binder W, Machelska H, Mousa S, Schmitt T, Riviere PJ, Junien JL, Stein C, and Schäfer M (2001) Analgesic and antiinflammatory effects of two novel kappa-opioid peptides. Anesthesiology 94:1034-1044.
6. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem 273:16865-16873.
7. Forse RA (2000) Biology of heterotrimeric G-protein signaling. Crit Care Med 28: 53-59.
8. Goff JR, Burkey AR, Goff DJ, and Jasmin L (1998) Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience 82:559-574.
9. Hilf G, Kupprion C, Wieland T, and Jakobs KH (1992) Dissociation of guanosine 5′-[gamma-thio]triphosphate from guanine-nucleotide-binding regulatory proteins in native cardiac membranes. Regulation by nucleotides and muscarinic acetylcholine receptors. Eur J Biochem 204:725-731.
10. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification (2003) Nomenclature guidelines for authors. Br J Pharmacol 138:725-729.
11. Ji RR, Zhang Q, Law PY, Low HH, Elde R, and Hokfelt T (1995) Expression of mu-, delta- and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15:8156-8166.
12. Julius D and Basbaum A (2001) Molecular mechanisms of nociception. Nature (Lond) 413:203-210.
13. Kenakin T (2002) Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol 42:349-379.
14. Kraus J, Borner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W, and Hollt V (2001) Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 276:43901-43908.
15. Likar R, Sittl R, Gragger K, Pipam W, Blatnig H, Breschan C, Schalk HV, Stein C, and Schäfer M (1998) Peripheral morphine analgesia in dental surgery. Pain 76:145-150.
16. Lindsay RM and Harmar AJ (1989) Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature (Lond) 337:362-364.
17. Maher CE, Selley DE, and Childers SR (2000) Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions. Biochem Pharmacol 59:1395-1401.
18. Millan MJ, Czlonkowski A, Morris B, Stein C, Arendt R, Huber A, Höllt V, and Herz A (1988) Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat. Pain 35:299-312.
19. Mousa SA, Machelska H, Schäfer M, and Stein C (2002) Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126:5-15.
20. Mousa SA, Zhang Q, Sitte N, Ji R, and Stein C (2001) beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115:71-78.
21. Neer EJ (1995) Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80:249-257.
22. 35S]Guanosine-5′-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. J Pharmacol Exp Ther 282:181-191.
23. 35S]thio)-triphosphate binding and antibody study. Mol Pharmacol 55:564-574.
24. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, and Reisine T (1994) Pharmacological characterization of the cloned kappa-, delta- and mu-opioid receptors. Mol Pharmacol 45:330-334.
25. Schäfer M, Imai Y, Uhl GR, and Stein C (1995) Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol 279:165-169.
26. 35S] GTP gamma S binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther 285:496-505.
27. Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, and Sim-Selley LJ (2001) Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. J Neurochem 77:1048-1057.
28. Silbert SC, Beacham DW, and McCleskey EW (2003) Quantitative single-cell differences in mu-opioid receptor mRNA MRN distinguish myelinated and unmyelinated nociceptors. J Neurosci 23:34-42.
29. 35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 92:7242-7246.
30. Spetea M, Rydelius G, Nylander I, Ahmed M, Bileviciute-Ljungar I, Lundeberg T, Svensson S, and Kreicbergs A (2002) Alteration in endogenous opioid systems due to chronic inflammatory pain conditions. Eur J Pharmacol 435:245-252.
31. Stein C, Machelska H, Binder W, and Schäfer M (2001) Peripheral opioid analgesia. Curr Opin Pharmacol 1:62-65.
32. Stein C, Millan MJ, and Herz A (1988) Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 31:455-451.
33. Stein C, Millan MJ, Shippenberg TS, Peter K, and Herz A (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 248:1269-1275.
34. Woolf CJ and Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science (Wash DC) 288:1765-1769.
35. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.
36. Zöllner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, and Schäfer M (2003) Painful inflammation induced increase in μ opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64:202-210.